Nephrocare Health Services debuted on stock exchanges with a 7% premium, opening at Rs 491.70 on BSE and Rs 490 on NSE. The company’s Rs 871.39 crore IPO saw robust demand, with QIBs and NIIs leading subscriptions. Nephrocare, India’s largest dialysis provider, aims to use IPO proceeds for debt reduction and expansion.